Tetraphase Pharmaceuticals, Inc.
TTPH
TTPH was delisted on the 28th of July, 2020.
90 hedge funds and large institutions have $152M invested in Tetraphase Pharmaceuticals, Inc. in 2017 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 27 increasing their positions, 23 reducing their positions, and 16 closing their positions.
17% more repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 23
1% more funds holding
Funds holding: 89 → 90 (+1)
6% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 16
11% less capital invested
Capital invested by funds: $170M → $152M (-$18.1M)
43% less call options, than puts
Call options by funds: $2.88M | Put options by funds: $5.09M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NI
Numeric Investors
Boston,
Massachusetts
|
+$5.43M |
| 2 |
EC
EcoR1 Capital
San Francisco,
California
|
+$4.89M |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
+$3.61M |
| 4 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$2.55M |
| 5 |
Millennium Management
New York
|
+$2.18M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
-$1.95M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$1.7M |
| 3 |
Two Sigma Investments
New York
|
-$867K |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$580K |
| 5 |
TCIM
TIAA CREF Investment Management
New York
|
-$477K |
TTPH Hedge Fund Activity: Q2 2017 in Review
90 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Tetraphase Pharmaceuticals, Inc. (TTPH) for Q2 2017, worth a combined $152M — down 11% from $170M a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new TTPH positions and 16 closed out — a net gain of 1 holder — while 27 added to existing stakes and 23 trimmed.
The largest buyer was Numeric Investors, adding an estimated $5.43M. The largest seller was Acadian Asset Management, cutting an estimated $1.95M.
- 90 institutional investors held Tetraphase Pharmaceuticals, Inc. (TTPH) as of Q2 2017, up from 89 in Q1 2017.
- Funds reported $152M of Tetraphase Pharmaceuticals, Inc. stock for Q2 2017, down 11% quarter-over-quarter.
- 17 funds opened new Tetraphase Pharmaceuticals, Inc. positions in Q2 2017 and 16 closed out, a net change of +1 holder.
- The largest Tetraphase Pharmaceuticals, Inc. buyer in Q2 2017 was Numeric Investors, an estimated $5.43M added.
- The largest Tetraphase Pharmaceuticals, Inc. seller in Q2 2017 was Acadian Asset Management, an estimated $1.95M sold.
Based on aggregated 13F filings for Q2 2017.